following a resubmission:
chloroprocaine hydrochloride (Ampres®) is accepted for restricted use for use within NHSScotland.
Indication under review: Spinal anaesthesia in adults where the planned surgical procedure should not exceed 40 minutes.
SMC restriction: for use in day-case anaesthetic pathways.
In a small, single-centre, randomised, double blind study in patients undergoing knee arthroscopy, spinal anaesthesia with chloroprocaine injection compared with a hyperbaric formulation of an amide-type local anaesthetic agent was associated with a faster motor block recovery
- Medicine name:
- chloroprocaine hydrochloride (Ampres)
- SMC ID:
Spinal anaesthesia in adults where the planned surgical procedure should not exceed 40 minutes.
- Pharmaceutical company
- Sintetica Limited
- BNF chapter
- Submission type
- Date advice published
- 11 October 2021